X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
53
PharmaCompass offers a list of Bosentan Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bosentan Hydrate manufacturer or Bosentan Hydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bosentan Hydrate manufacturer or Bosentan Hydrate supplier.
PharmaCompass also assists you with knowing the Bosentan Hydrate API Price utilized in the formulation of products. Bosentan Hydrate API Price is not always fixed or binding as the Bosentan Hydrate Price is obtained through a variety of data sources. The Bosentan Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bosentan Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bosentan Monohydrate, including repackagers and relabelers. The FDA regulates Bosentan Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bosentan Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bosentan Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bosentan Monohydrate supplier is an individual or a company that provides Bosentan Monohydrate active pharmaceutical ingredient (API) or Bosentan Monohydrate finished formulations upon request. The Bosentan Monohydrate suppliers may include Bosentan Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Bosentan Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bosentan Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Bosentan Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of Bosentan Monohydrate DMFs exist exist since differing nations have different regulations, such as Bosentan Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bosentan Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Bosentan Monohydrate USDMF includes data on Bosentan Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bosentan Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bosentan Monohydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bosentan Monohydrate Drug Master File in Japan (Bosentan Monohydrate JDMF) empowers Bosentan Monohydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bosentan Monohydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Bosentan Monohydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bosentan Monohydrate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bosentan Monohydrate Drug Master File in Korea (Bosentan Monohydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bosentan Monohydrate. The MFDS reviews the Bosentan Monohydrate KDMF as part of the drug registration process and uses the information provided in the Bosentan Monohydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bosentan Monohydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bosentan Monohydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bosentan Monohydrate suppliers with KDMF on PharmaCompass.
A Bosentan Monohydrate written confirmation (Bosentan Monohydrate WC) is an official document issued by a regulatory agency to a Bosentan Monohydrate manufacturer, verifying that the manufacturing facility of a Bosentan Monohydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bosentan Monohydrate APIs or Bosentan Monohydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Bosentan Monohydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Bosentan Monohydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bosentan Monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bosentan Monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bosentan Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bosentan Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bosentan Monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bosentan Monohydrate suppliers with NDC on PharmaCompass.
Bosentan Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bosentan Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bosentan Monohydrate GMP manufacturer or Bosentan Monohydrate GMP API supplier for your needs.
A Bosentan Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Bosentan Monohydrate's compliance with Bosentan Monohydrate specifications and serves as a tool for batch-level quality control.
Bosentan Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Bosentan Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bosentan Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bosentan Monohydrate EP), Bosentan Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bosentan Monohydrate USP).
Market Place
